Andrew Ferguson

Andrew Ferguson, CA-AM, PhD, currently serves as the Director of Global Oncology R&D Alliance Management at Takeda Oncology, where responsibility includes leading discovery and clinical development alliances while ensuring alignment with business and scientific goals. Previously, Andrew held the position of Director of Portfolio & Alliance Management at X-Chem, Inc., managing strategic alliances with pharmaceutical and biotech companies. Earlier career highlights include roles as a Principal Scientist II at AstraZeneca, where Andrew directed scientific projects and alliance management, and as an Associate Principal Scientist at both Schering-Plough Research Institute and Merck, contributing to drug discovery and structural biology efforts. Andrew began an academic career as a Postdoctoral Fellow at UT Southwestern Medical Center, following the completion of a PhD in Microbiology and Immunology from McGill University and a Graduate Certificate in Biopharmaceutical Leadership from Emmanuel College.